A randomized, double-blinded, placebo-controlled study evaluating the efficacy and safety of nabilone as an adjunctive to gabapentin in managing multiple sclerosis-induced neuropathic pain: An interim analysis

Authors
Category Primary study
JournalPain Research and Management
Year 2011
This article has no abstract
Epistemonikos ID: c3c65a31b5a672284855f85075dbea9f8836d042
First added on: Feb 04, 2025